Manuel Nava

709 total citations
27 papers, 489 citations indexed

About

Manuel Nava is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Manuel Nava has authored 27 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Manuel Nava's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Natural Antidiabetic Agents Studies (4 papers) and Diabetes Treatment and Management (3 papers). Manuel Nava is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Natural Antidiabetic Agents Studies (4 papers) and Diabetes Treatment and Management (3 papers). Manuel Nava collaborates with scholars based in Venezuela, Colombia and United States. Manuel Nava's co-authors include Valmore Bermúdez, Joselyn Rojas, Milagros Rojas, Juan Salazar, Ángel Ortega, Mervin Chávez-Castillo, Luis Carlos Olivar, María Sofía Martínez, Manuel Velasco and Maricarmen Chacín and has published in prestigious journals such as New England Journal of Medicine, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Manuel Nava

26 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Nava Venezuela 13 149 131 120 90 57 27 489
Ana Paula Bouças Brazil 15 116 0.8× 155 1.2× 216 1.8× 130 1.4× 90 1.6× 28 654
Weihua Wu China 10 107 0.7× 171 1.3× 72 0.6× 41 0.5× 33 0.6× 14 474
Rosana Cristina Tieko Mori Brazil 12 94 0.6× 144 1.1× 105 0.9× 71 0.8× 45 0.8× 19 365
Sebastiano Raimondo Italy 12 228 1.5× 159 1.2× 129 1.1× 36 0.4× 52 0.9× 21 727
Raffaella Marin Italy 12 102 0.7× 89 0.7× 82 0.7× 160 1.8× 67 1.2× 28 489
Yunjuan Gu China 12 191 1.3× 183 1.4× 113 0.9× 79 0.9× 27 0.5× 31 537
Nobuyuki Shihara Japan 15 240 1.6× 251 1.9× 140 1.2× 175 1.9× 112 2.0× 22 618
Jiang‐Rui Zhou China 13 50 0.3× 216 1.6× 106 0.9× 91 1.0× 41 0.7× 16 658
Małgorzata Bednarska‐Makaruk Poland 14 54 0.4× 114 0.9× 160 1.3× 128 1.4× 31 0.5× 50 583

Countries citing papers authored by Manuel Nava

Since Specialization
Citations

This map shows the geographic impact of Manuel Nava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Nava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Nava more than expected).

Fields of papers citing papers by Manuel Nava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Nava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Nava. The network helps show where Manuel Nava may publish in the future.

Co-authorship network of co-authors of Manuel Nava

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Nava. A scholar is included among the top collaborators of Manuel Nava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Nava. Manuel Nava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durán, Pablo, et al.. (2025). Immunology of Hypertension: Pathophysiological and Therapeutic Aspects. International Journal of Molecular Sciences. 26(20). 9921–9921.
2.
Nava, Manuel, et al.. (2024). Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?. Biomedicines. 12(2). 283–283. 1 indexed citations
3.
Ortega, Ángel, Juan Salazar, Milagros Rojas, et al.. (2022). Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy. International Journal of Molecular Sciences. 23(8). 4196–4196. 10 indexed citations
4.
Salazar, Juan, Manuel Nava, Ana Valéria Castro, et al.. (2022). Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. International Journal of Molecular Sciences. 23(6). 3133–3133. 15 indexed citations
5.
D’Marco, Luis, Ana Checa-Ros, Carlos Soto, et al.. (2022). Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation. Healthcare. 11(1). 72–72. 5 indexed citations
6.
Rojas, Milagros, Mervin Chávez-Castillo, Manuel Nava, et al.. (2021). Metabolic Syndrome: Is It Time to Add the Central Nervous System?. Nutrients. 13(7). 2254–2254. 27 indexed citations
7.
D’Marco, Luis, José Luis Górriz, Manuel Nava, et al.. (2021). SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence. Journal of Diabetes Research. 2021. 1–17. 14 indexed citations
8.
Salazar, Juan, Carla Navarro, Ángel Ortega, et al.. (2021). Advanced Glycation End Products: New Clinical and Molecular Perspectives. International Journal of Environmental Research and Public Health. 18(14). 7236–7236. 40 indexed citations
9.
Bermúdez, Valmore, Juan Salazar, Manuel Nava, et al.. (2021). Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela. Journal of Obesity. 2021. 1–7. 9 indexed citations
10.
Martínez, María Sofía, Luis Carlos Olivar, Manuel Nava, et al.. (2021). The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror. International Journal of Molecular Sciences. 22(17). 9504–9504. 20 indexed citations
11.
Bermúdez, Valmore, Juan Salazar, María Sofía Martínez, et al.. (2021). Age-specific waist circumference cutoff-points for abdominal obesity diagnosis: a personalized strategy for a large Venezuelan population. Journal of Diabetes & Metabolic Disorders. 20(1). 217–227. 1 indexed citations
12.
Bermúdez, Valmore, Pablo Durán, Edward Rojas, et al.. (2021). The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium. Frontiers in Endocrinology. 12. 735070–735070. 17 indexed citations
13.
Rojas, Edward, et al.. (2020). Diagnostic criteria and management of metabolic syndrome: Evolution overtime. Gaceta Médica de Caracas. 128(4). 480–504. 6 indexed citations
14.
Torres, Wheeler, Manuel Nava, Milagros Rojas, et al.. (2020). Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective. Current Pharmaceutical Design. 26(35). 4496–4508. 21 indexed citations
15.
Bermúdez, Valmore, Juan Salazar, Manuel Nava, et al.. (2020). Análisis clínico-epidemiológico de las subfracciones HDL2 y HDL3 en adultos de la ciudad de Maracaibo, Venezuela. Revista Peruana de Medicina Experimental y Salud Pública. 37(3). 412–22. 1 indexed citations
16.
Chávez-Castillo, Mervin, Manuel Nava, Ángel Ortega, et al.. (2020). Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease. Current Neuropharmacology. 18(11). 1138–1153. 12 indexed citations
17.
Salazar, Juan, Mervin Chávez-Castillo, Joselyn Rojas, et al.. (2019). Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?. Current Diabetes Reviews. 16(7). 733–749. 9 indexed citations
18.
Chávez-Castillo, Mervin, Victoria Núñez, Manuel Nava, et al.. (2019). Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. Advances in Pharmacological Sciences. 2019. 1–20. 40 indexed citations
19.
Nava, Manuel, et al.. (2019). Green and hawksbill turtle abundance and population dynamics at foraging grounds in Bonaire, Caribbean Netherlands. Endangered Species Research. 40. 243–256. 1 indexed citations
20.
Rojas, Joselyn, Valmore Bermúdez, María Sofía Martínez, et al.. (2018). Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy. Journal of Diabetes Research. 2018. 1–19. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Paula Bouças Breakdown of academic impact, for papers by Weihua Wu Breakdown of academic impact, for papers by Rosana Cristina Tieko Mori Breakdown of academic impact, for papers by Sebastiano Raimondo Breakdown of academic impact, for papers by Raffaella Marin Breakdown of academic impact, for papers by Yunjuan Gu Breakdown of academic impact, for papers by Nobuyuki Shihara Breakdown of academic impact, for papers by Jiang‐Rui Zhou Breakdown of academic impact, for papers by Małgorzata Bednarska‐Makaruk
Rankless by CCL
2026